Format

Send to

Choose Destination
Nat Cell Biol. 2019 Apr;21(4):534. doi: 10.1038/s41556-019-0288-3.

Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.

Author information

1
Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
2
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, 10065, USA.
3
Breast Unit, Royal Marsden Hospital, London, SW3 6JJ, UK.
4
Department of Surgery and Center for Cell Engineering, Memorial Sloan-Kettering Cancer Center, New York, 10065, USA.
5
Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
6
Department of Pediatrics, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
7
The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, USA.
8
Department of Biomedical Sciences and Human Oncology, Center of Experimental Medicine and Research, University of Torino, Torino, 10126, Italy.
9
Department of Surgery, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
10
Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
11
Genomics Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
12
Geoffrey Beene Translational Oncology Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
13
Department of Pathology, Office for Collaborative Science, New York University, New York, 10016, USA.
14
Bioinformatics Core Facility, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
15
Department of Medical Sciences, Center of Experimental Medicine and Research, University of Torino, Torino, 10126, Italy.
16
Department of Epidemiology and Biostatistics, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
17
Structural Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
18
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, 10065, USA.
19
Department of Medicine, Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA.
20
Cell Biology Program, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York, 10065, USA. f-giancotti@ski.mskcc.org.

Abstract

In the version of this Article originally published the same blot was inadvertently presented as both p-Rb and Cyclin A in Fig. 2a. This blot corresponds to the p-Rb panel, as can be seen in the unprocessed version of these blots in Supplementary Fig. 9. The corrected version of the panel is shown below, together with a completely uncropped image of both blots. In addition, in the 'Viral transduction' section of the Methods, the pLKO.1 plasmids encoding short hairpin RNAs targeting human Rnd1 were incorrectly listed as clones TRCN0000018338 and TRCN0000039977. The correct clone numbers are TRCN0000047434 and TRCN0000047435.

PMID:
30842593
DOI:
10.1038/s41556-019-0288-3

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center